To deliver these therapies to the patients who need them, their success hinges on effective storage and management to maintain integrity throughout their lifecycle. From early development to commercialization, safeguarding sensitive biological materials demands scalable storage solutions and meticulous risk mitigation strategies. Partnering with a CDMO specializing in ultracold storage and biorepository management is critical to preserving product integrity and ensuring continuity throughout every development stage. This webinar will explore how the right CDMO partner can streamline biological material storage, mitigate risks, and provide the scalability needed to support growth from clinical trials to commercial launch, empowering you to advance your pipeline with confidence. Participants will gain insight into:

Financial burdens are cited as one of the main barriers to clinical trial recruitment and retention, with traditional methods proving unreliable, complicated and slow. For trial sites and sponsors, the administration burden can be overwhelming, especially on a global scale. Discover how IQVIA’s Participant Payment service is transforming the participant payment landscape, simplifying the process and driving clinical trial success, by offering:

The field of precision medicine is rapidly evolving, enabling the development of innovative therapies highly tailored to individuals’ genetic profiles - resulting in revolutionized treatments and improved patient outcomes. Discover expert insights on the current landscape of personalized medicine, including the opportunities and challenges, including:

Discover new insights into coordinating medtech quality processes and platforms to successfully achieve global quality and regulatory harmonization. Explore the considerations of harmonization and understand how it can help organizations comply with impending Quality Management System Regulation (QMSR) updates from the U.S. Food and Drug Administration (FDA). Read now to learn how medtech organizations can:

Amidst a surge of innovation, the biologics market faces unpredictability over volume needs in drug development. Companies are increasingly turning to CDMOs for flexible operation strategies, to adapt to changing manufacturing demands, and for long-term confidence and security. Discover the crucial factors for success in the volatile biologics market, as they explore:

Discover how AI and automation can transform pharmacovigilance in this insightful webinar. This webinar session will explore the evolution of the ARTEMIS (Adverse Event Processing using Technology Enabled Medical and Intelligent Solution) project launched by PSPV and Sanofi Digital 6 years ago with a previous partner which was achieving significant benefits through NLP and Artificial Intelligence. Then due to unforeseen constraints Sanofi started working with IQVIA to move to a new system within 6 months and continue the journey of optimization and improvement. This partnership showcases how organizations can stay adaptable, even through shifting circumstances, to sustain momentum in digital safety innovation. Key Takeaways:

Download now to learn more about using IRT/RTSM to:

Join us for expert insights into:

Don’t miss insights from a recent recorded panel discussion among the subject matter area experts at Certara. Watch on demand to: